Zobrazeno 1 - 10
of 404
pro vyhledávání: '"Karin Dieckmann"'
Autor:
Adrian Damek, Lars Kurch, Friedrich Christian Franke, Andishe Attarbaschi, Auke Beishuizen, Michaela Cepelova, Francesco Ceppi, Stephen Daw, Karin Dieckmann, Ana Fernández-Teijeiro, Tobias Feuchtinger, Jamie E. Flerlage, Alexander Fosså, Thomas W. Georgi, Dirk Hasenclever, Andrea Hraskova, Jonas Karlen, Tomasz Klekawka, Regine Kluge, Dieter Körholz, Judith Landman-Parker, Thierry Leblanc, Christine Mauz-Körholz, Markus Metzler, Jane Pears, Jonas Steglich, Anne Uyttebroeck, Dirk Vordermark, William Hamish Wallace, Walter Alexander Wohlgemuth, Dietrich Stoevesandt
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Hypodense volumes (HDV) in mediastinal masses can be visualized in a computed tomography scan in Hodgkin lymphoma. We analyzed staging CT scans of 1178 patients with mediastinal involvement from the EuroNet-PHL-C1 trial and explored correlat
Externí odkaz:
https://doaj.org/article/56fe25c1577a4d6ebc0c24ea6b216610
Autor:
Fiona Poyer, Karin Dieckmann, Michael Dworzak, Melanie Tamesberger, Oskar Haas, Neil Jones, Karin Nebral, Stefan Köhrer, Reinhard Moser, Gabriele Kropshofer, Christina Peters, Christian Urban, Georg Mann, Ulrike Pötschger, Andishe Attarbaschi, the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 940-948 (2022)
Abstract Second malignant neoplasms (SMN) after primary childhood acute lymphoblastic leukemia (ALL) are rare. Among 1487 ALL patients diagnosed between 1981 and 2010 in Austria, the 10‐year cumulative incidence of an SMN was 1.1% ± 0.3%. There wa
Externí odkaz:
https://doaj.org/article/eb27500785414888a203fb3d6a9f37ae
Autor:
Irene Slavc, Lisa Mayr, Natalia Stepien, Johannes Gojo, Maria Aliotti Lippolis, Amedeo A. Azizi, Monika Chocholous, Alicia Baumgartner, Cora S. Hedrich, Stefan Holm, Astrid Sehested, Pierre Leblond, Karin Dieckmann, Christine Haberler, Thomas Czech, Marcel Kool, Andreas Peyrl
Publikováno v:
Cancers, Vol 14, Iss 20, p 5128 (2022)
Medulloblastoma (MB) recurrence is usually incurable despite intensive therapy including high-dose chemotherapy. An evolving alternative approach to conventional chemotherapy aims at interfering with tumor angiogenesis at different levels. We report
Externí odkaz:
https://doaj.org/article/3967e403e9c24bd7a10c73b3d480d831
Autor:
Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, Gerwin Heller, Barbara Kiesel, Kristina Tendl-Schulz, Zsuzsanna Bago-Horvath, Julia Furtner, Johannes Leitner, Ruth Exner, Florian Fitzal, Karin Dieckmann, Georg Widhalm, Matthias Preusser, Anna Sophie Berghoff, Rupert Bartsch
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab (TP) is a standard therapy of metastatic and localized HER2-positive breast cancer (BC), but its activity in breast cancer brain metastases (BCB
Externí odkaz:
https://doaj.org/article/4eb2fe5fd3694a6a890ef4fe3c3a3a7b
Autor:
Lisa Mayr, Johannes Gojo, Andreas Peyrl, Amedeo A. Azizi, Natalia M. Stepien, Thomas Pletschko, Thomas Czech, Christian Dorfer, Sander Lambo, Karin Dieckmann, Christine Haberler, Marcel Kool, Irene Slavc
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Embryonal tumor with multilayered rosettes (ETMR) is a rare, aggressive embryonal central nervous system tumor characterized by LIN28A expression and alterations in the C19MC locus. ETMRs predominantly occur in young children, have a dismal prognosis
Externí odkaz:
https://doaj.org/article/bc74f8f9dbc94b85bc346c956b44e4fc
Autor:
Maximilian J Mair, Sahra Pajenda, Barbara Kiesel, Georg Widhalm, Karin Dieckmann, Katharina Feldmann, Johannes Hainfellner, Ludwig Wagner
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Background Immune-modulatory treatments have so far shown limited clinical activity in primary brain tumours. We aimed to investigate soluble programmed death receptor ligand 1 (sPD-L1) as systemic inflammation parameter in patients with brain tumour
Externí odkaz:
https://doaj.org/article/187c734408a344178ceb71d07c3ec6e8
Autor:
Sara R. Alcorn MD, MPH, PhD, Xian Chiong Zhou MS, Casey Bojechko PhD, Rodrigo A. Rubo BS, Michael J. Chen MD, Karin Dieckmann MD, Ralph P. Ermoian MD, Eric C. Ford PhD, Daria Kobyzeva MD, Shannon M. MacDonald MD, Todd R. McNutt PhD, Alexey Nechesnyuk MD, Kristina Nilsson MD, PhD, Hakan Sjostrand BS, Koren S. Smith MS, Markus Stock PhD, Erik J. Tryggestad PhD, Rosangela C. Villar MD, Brian A. Winey PhD, Stephanie A. Terezakis MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Background: Lower-dose cone-beam computed tomography protocols for image-guided radiotherapy may permit target localization while minimizing radiation exposure. We prospectively evaluated a lower-dose cone-beam protocol for central nervous system ima
Externí odkaz:
https://doaj.org/article/63272d7e5e25499289ab133f3b5a6ca6
Autor:
Stephen Daw, Dirk Hasenclever, Maurizio Mascarin, Ana Fernández-Teijeiro, Walentyna Balwierz, Auke Beishuizen, Roberta Burnelli, Michaela Cepelova, Alexander Claviez, Karin Dieckmann, Judith Landman-Parker, Regine Kluge, Dieter Körholz, Christine Mauz-Körholz, William Hamish Wallace, Thierry Leblanc, on behalf of the EuroNet Paediatric Hodgkin Lymphoma Group
Publikováno v:
HemaSphere, Vol 4, Iss 1, p e329 (2020)
Abstract. The objective of this guideline is to aid clinicians in making individual salvage treatment plans for pediatric and adolescent patients with first relapse or refractory (R/R) classical Hodgkin lymphoma (cHL). While salvage with standard dos
Externí odkaz:
https://doaj.org/article/d7343141f1694de29a9be7c881506871
Autor:
Stefan Fiedler, Inge M. Ambros, Evgenia Glogova, Martin Benesch, Christian Urban, Marlene Mayer, Georg Ebetsberger-Dachs, Edit Bardi, Neil Jones, Agnes Gamper, Bernhard Meister, Roman Crazzolara, Gabriele Amann, Karin Dieckmann, Ernst Horcher, Reinhold Kerbl, Bettina Brunner-Herglotz, Andrea Ziegler, Peter F. Ambros, Ruth Ladenstein
Publikováno v:
Cancers, Vol 13, Iss 3, p 572 (2021)
We evaluated long-term outcome and genomic profiles in the Austrian Neuroblastoma Trial A-NB94 which applied a risk-adapted strategy of treatment (RAST) using stage, age and MYCN amplification (MNA) status for stratification. RAST ranged from surgery
Externí odkaz:
https://doaj.org/article/5805061fa72341b394b920788cf15a87
Autor:
Lisa Mayr, Armin S. Guntner, Sibylle Madlener, Maria T. Schmook, Andreas Peyrl, Amedeo A. Azizi, Karin Dieckmann, Dominik Reisinger, Natalia M. Stepien, Kathrin Schramm, Anna Laemmerer, David T. W. Jones, Jonas Ecker, Felix Sahm, Till Milde, Kristian W. Pajtler, Mirjam Blattner-Johnson, Miroslav Strbac, Christian Dorfer, Thomas Czech, Dominik Kirchhofer, Lisa Gabler, Walter Berger, Christine Haberler, Leonhard Müllauer, Wolfgang Buchberger, Irene Slavc, Daniela Lötsch-Gojo, Johannes Gojo
Publikováno v:
Journal of Personalized Medicine, Vol 10, Iss 4, p 290 (2020)
Targeting oncogenic fusion-genes in pediatric high-grade gliomas (pHGG) with entrectinib has emerged as a highly promising therapeutic approach. Despite ongoing clinical studies, to date, no reports on the treatment of cerebrospinal fluid (CSF) disse
Externí odkaz:
https://doaj.org/article/203f2e5e61404912a3032246dca2ba27